Like this site? Help us to make it better.


Katusha's Denis Galimzyanov provisionally suspended by UCI after testing positive for EPO

Positive test resulted from urine sample taken in out-of-competition test last month

World cycling's governing body, the UCI, has provisionally suspended Katusha sprinter Denis Galimzyanov after the sprinter tested positive for EPO following an out-of-competition test taken last month.

in a statement, the UCI said: "The decision to provisionally suspend this rider was made in response to a report from the WADA accredited laboratory in Cologne indicating an Adverse Analytical Finding of EPO in a urine sample collected from him in an out of competition test on 22 March 2012.

"The provisional suspension of Mr Galimzyanov remains in force until a hearing panel convened by the Russian Cycling Federation determines whether he has committed an anti-doping rule violation under Article 21 of the UCI Anti-Doping Rules." it continued.

"Mr Galimzyanov has the right to request and attend the analysis of his B sample" the UCI added.

Aged 25, Galimzyanov turned professional with Katusha in 2009, having spent the provious year with its Katusha Continental under-23 team, and his profile has steadily been rising since then.

Last year, the Russian finished second to Mark Cavendish in the Scheldeprijs, and secured victories in Paris-Brussels as well as stage victories in the Tour of Luxembourg, the Tour of Beijing and the Three Days of De Panne, also taking the points classification in the latter race.

His sole victory to date in 2012 came in the opening stage of the Circuit de la Sarthe earlier this month. He is currently recovering from injuries received in a crash towards the end of the following day's stage.

Galizmyanov is the second high-profile Katusha rider to have failed a doping control inside the last year. World championship and Olympic road race medallist Alexander Kolobnev was sacked by the team last summer after testing positive for hydrochlorothiazide during last July's Tour de France.

The Russian cycling federation fined the rider but did not impose a ban on him, accepting his excuse that the substance, which can be used as a masking agent for EPO, was contained in an over-the-counter medicine available in Russia that his doctor there had recommended him to use.

The UCI appealed that decision to the Court fo Arbitration for Sport but was unsuccessful, and last month Katusha confiirmed that it had agreed a new contract with Kolobnev.

Simon has been news editor at since 2009, reporting on 10 editions and counting of pro cycling’s biggest races such as the Tour de France, stories on issues including infrastructure and campaigning, and interviewing some of the biggest names in cycling. A law and languages graduate, published translator and former retail analyst, his background has proved invaluable in reporting on issues as diverse as cycling-related court cases, anti-doping investigations, and the bike industry. He splits his time between London and Cambridge, and loves taking his miniature schnauzer Elodie on adventures in the basket of her Elephant Bike.

Latest Comments